Updated Position of the Spanish Psoriasis Group (GPs) on the Use of Biosimilar Drugs in Moderate to Severe Psoriasis R. Ruiz-Villaverde, M. Galán-Gutiérrez, M. Llamas-Velasco, L. Salgado-Boquete, L. Puig, P. de la Cueva, J.M. Carrascosa

Updated Perspective from the Spanish Psoriasis Working Group (GPS) on Biosimilar Drug Use in Moderate-to-Severe Psoriasis L. Salgado-Boquete, L. Puig, J.M. Carrascosa, P. de la Cueva, A. López Ferrer

Effectiveness and Drug Survival of Apremilast in 65 Patients With Psoriasis and/or Psoriatic Arthritis P. Garbayo Salmons, V. Expósito Serrano, J. Romaní de Gabriel, M. Ribera Pibernat